U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07128628) titled 'A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease' on Aug. 06.
Brief Summary: A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Dry Eye Disease
Intervention:
DRUG: Lifitegrast/Perfluorohexyloctane Fixed Dose Combination
Topical ocular drop of lifitegrast and perfluorohexyloctane administered for 4 weeks
DRUG: Lifitegrast
Topical ocular drop of lifi...